These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6415090)

  • 1. Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients.
    Cukor G; Blacklow NR; Nowak NA; Rich CM; Braverman LE; Fischer RA
    J Clin Microbiol; 1983 Sep; 18(3):457-62. PubMed ID: 6415090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
    Jagger KS; Robinson DL; Franz MN; Warren RL
    J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
    J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
    JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    Klinger JD; Straus DC; Hilton CB; Bass JA
    J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
    Doggett RG; Harrison GM
    Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
    Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G
    APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.
    Crowe KE; Bass JA; Young VM; Straus DC
    J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Lang A; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Schaad U
    Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.
    Moore R; Kyd JM; Carzino R; Armstrong D; Grimwood K; Otczyk DC; Cripps AW
    Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
    Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML
    Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.
    Corech R; Rao A; Laxova A; Moss J; Rock MJ; Li Z; Kosorok MR; Splaingard ML; Farrell PM; Barbieri JT
    J Clin Microbiol; 2005 Aug; 43(8):3956-62. PubMed ID: 16081936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.
    Grzybowski J; Trafny EA; Wrembel-Wargocka J; Patzer J; Dzierzanowska D; Zawistowska-Marciniak I; Kłos M
    J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
    Hayes D; Farrell PM; Li Z; West SE
    Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
    Trancassini M; De Vito D; Quattrucci S; Cipriani P
    New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.
    Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW
    J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serodiagnosis of Pseudomonas aeruginosa infections in mucoviscidosis: comparative study of Western blotting, ELISA exotoxin A and ELISA phospholipase C].
    Fournier C; Andre J; Marlier H; Guinet R; Gilly R
    Pathol Biol (Paris); 1993 Nov; 41(9):856-64. PubMed ID: 8121717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
    Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.